Among these, drugs targeting a specific receptor or channel at the transmembrane level have proven effectiveness, bringing them to the level of major therapeutic approaches such as fluoxetine for treating depression and GLP-1 as an antidiabetic. The gene discussed is GLP1R; the disease is major depressive disorder.